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Abstract: Arylalkylamine N-acetyltransferase (AANAT) catalyzes the transfer of an acetyl 
group from acetyl coenzyme A (AcCoA) to arylalkylamines, including indolethylamines 
and phenylethylamines. Multiple aanats are present in teleost fish as a result of whole 
genome and gene duplications. Fish aanat1a and aanat2 paralogs display different patterns 
of tissue expression and encode proteins with different substrate preference: AANAT1a is 
expressed in the retina, and acetylates both indolethylamines and phenylethylamines; while 
AANAT2 is expressed in the pineal gland, and preferentially acetylates indolethylamines. 
The  two  enzymes  are  therefore  thought  to  serve  different  roles.  Here,  the  molecular 
changes that led to their specialization were studied by investigating the structure-function 
relationships of AANATs in the gilthead seabream (sb, Sperus aurata). Acetylation activity 
of  reciprocal  mutated  enzymes  pointed  to  specific  residues  that  contribute  to  substrate 
specificity of the enzymes. Inhibition tests followed by complementary analyses of the 
predicted three-dimensional models of the enzymes, suggested that both phenylethylamines 
and indolethylamines bind to the catalytic pocket of both enzymes. These results suggest 
that substrate selectivity of AANAT1a and AANAT2 is determined by the positioning of 
the substrate within the catalytic pocket, and its accessibility to catalysis. This illustrates the 
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evolutionary  process  by  which  enzymes  encoded  by  duplicated  genes  acquire  different 
activities and play different biological roles.  
Keywords: seabream; serotonin; dopamine; gene duplication 
 
1. Introduction 
Arylalkylamine  N-acetyltransferase  (AANAT)  belongs  to  the  large  GNAT  acetyltransferases 
superfamily,  members  of  which  are  found  in  all  kingdoms  of  life  [1],  reflecting  the  fundamental 
importance of acetyl transfer. Members of the GNAT superfamily acetylate a wide range of substrates, 
ranging from small molecules to large proteins [2]. AANATs selectively acetylate arylalkylamines, 
including indolethylamines and phenylethylamines [3–7]. 
Members of the AANAT family are expressed in the vertebrate pineal gland and retina; homologs 
are found in amphioxus, fungi, algae and bacteria [8,9]. In the vertebrate pineal the gland, AANAT 
functions  in  the  melatonin  synthesis  pathway  by  catalyzing  acetylation  of  serotonin,  resulting  in  
N-acetylserotonin; the latter is O-methylated by hydroxyindole-O-methyltransferase (HIOMT) to form 
the hormone melatonin. Melatonin is produced in a rhythmic manner with high levels during the night 
and low levels during the day. These temporal changes are controlled by the activity of AANAT [10,11]. 
Accordingly, AANAT is considered the key enzyme in the generation of the melatonin rhythm. 
AANAT is a globular protein (20–25 kDa) comprised of a catalytic domain flanked by regulatory 
domains. The catalytic domain includes the AcCoA binding region found in other members of the 
GNAT superfamily and three AANAT-defining loops that form the arylalkylamine binding pocket. 
The kinetic mechanism of AANAT obeys an ordered BiBi ternary complex (sequential) where the 
binding of AcCoA precedes the binding of the amine substrate [12]. Crystallographic analysis of the 
sheep AANAT indicated that the reactive groups (i.e., the primary amine and the acetyl group) are 
positioned  in  close  proximity  within  the  catalytic  funnel  [13–17].  Catalysis  is  initiated  by 
deprotonation of the protonated amine, indirectly facilitated by neighboring histidines (His
120,122). The 
two histidines are part of a proton wire that channels protons to the surface of the enzyme. This 
deprotonation leads to nucleophilic attack on the thioester bond of AcCoA. Protonation of the CoA 
thiolate-leaving group is facilitated by a conserved tyrosine (Tyr
168). 
In mammals and chicken, only a single aanat gene has been identified, which is expressed in the 
pineal gland and in the retina. In teleost fish, multiple aanat genes, aanat1a, aanat1b and aanat2, have 
been identified and characterized [8,18–23]. The existence of multiple aanats in fish is likely to be the 
result of a genome and gene duplications that occurred after the divergence of teleosts and the tetrapod 
lineage [8,24,25]. Genome duplications are important molecular evolutionary forces that allow the 
duplicate genes to acquire new or related functions, or to alter their expression pattern, a process 
known also as co-option [24,26]. Such an evolutionary process is apparent from studies on aanat1a 
and aanat2. These genes display different patterns of tissue expression and encode proteins that have 
different  kinetic  characteristics  and  substrate  preference,  consistent  with  different  functions. 
AANAT1a  is  expressed  mainly  in  the  retina  and  to  some  extent  also  in  the  brain,  and,  like  the 
mammalian and avian AANATs, acetylates both indolethylamines and phenylethylamines. AANAT2 Mar. Drugs 2011, 9                      
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is primarily expressed in the pineal gland and preferentially acetylates indolethylamines, especially 
serotonin [23,27]. The activity of AANAT2 is characterized by weaker affinity and higher velocity for 
its substrates as compared to those of AANAT1a [18,22,28]. The biological significance of multiple 
AANATs in fish is likely to represent evolutionary responses to different selective pressures. While 
AANAT2 may have acquired a higher selectivity for serotonin in order to enhance the efficiency of 
melatonin production [8,29], AANAT1a preserved a broad arylalkylamine acetylation capability so 
that it could serve multiple functions in the retina. Thus, retinal AANAT may play other roles in 
addition  to  being  involved  in  melatonin  synthesis.  Through  the  acetylation  of  dopamine,  retinal 
AANAT may contribute to the control of dopamine levels or initiate the synthesis of a novel bioactive 
molecule [29]. Retinal AANAT may also play a more general role in detoxification through its action 
on a broad range of arylalkylamines [8,30]. AANAT1b and AANAT1a are closely-related proteins 
with  high  homology  and  identical  substrate  binding  and  catalytic  sites.  Although  the  biochemical 
properties of AANAT1b are still unknown, the presence of the three AANATs in some fish species 
supports the hypothesis that these enzymes play multiple roles [31,32]. 
The presence of multiple AANATs in fish provides an opportunity to study the effect of natural 
mutations in these closely-related molecules. Here we investigate the structure-function relationship of 
seabream AANAT1a and AANAT2, by attempting to identify the molecular basis of their kinetic 
differences  and  substrate  preference.  Inhibition  experiments  were  performed  to  assess  the  binding 
capabilities of AANAT1a and AANAT2 to their different substrates. Site-directed mutagenesis was 
used to determine the importance of residues in the arylalkylamine binding domain that differ between 
the two enzymes. In addition, the predicted structures of wild type AANAT1a and AANAT2 were 
compared in regard to their capacity to bind arylalkylamines. The results of these studies provide a 
foundation for a molecular explanation of the functional differences between AANAT1a and AANAT2. 
2. Results and Discussion 
2.1. Kinetic Characterization of Mutated AANAT1a and AANAT2 
Fish have become important models for the evolutionary significances of gene duplication since 
many gene families possess more members in fish than in mammals. Two evolutionary processes can 
lead to a protein with a novel function: a change in the coding sequence of the gene that alters the 
biochemical properties of the protein, and a change in its regulatory sequence that alters its temporal or 
spatial expression pattern [26]. The duplicate AANATs in fish illustrate these evolutionary processes 
by representing differences, both in their spatio-temporal expression patterns [18,27,33,34] and in their 
biochemical properties [18,22,28]. The different qualities of each enzyme are thought to serve two 
melatonin generating systems, one in the retina and the other in the pineal gland [18,21,22]. It has also 
been suggested that AANAT1a is involved in dopamine metabolism and amine detoxification in the 
retina [8,29]. 
In the current study the molecular-structural base for the differences between the two enzymes was 
biochemically investigated, followed by in silico experiments. Mar. Drugs 2011, 9                      
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The effect of reciprocal mutation (See ‗Experimental Section‘ for details, Figure 1, Table 1) on the 
activity of the two enzymes was measured in order to study the molecular basis that underlies the 
biochemical differences. 
Figure  1.  Sequence  alignment  of  sheep  AANAT,  seabream  AANAT1a  and  seabream 
AANAT2. The alignment starts in residue 30 of the sheep AANAT, in residue 25 of the 
seabream AANAT1a, and in residue 28 of the seabream AANAT2. The coloring of the 
alignment  follows  the  sequence  similarity  between  AANAT1a  or  AANAT2  and  the 
sequence of the sheep AANAT; identical residues are shaded and colored in white, similar 
residues are shaded. The secondary structure elements, as analyzed by Hickman et al. [15] 
and Dyda et al. [2], are shown above the residues. The mutation sites are boxed. The 
pairwise alignment was done using the Needle alignment tool.   
 
Table  1.  Mutation  sites  in  AANAT1a  and  AANAT2  and  the  comparable  sites  in  the  
sheep AANAT.  
                  Mutation sites   
Mutation 
region/name 
AANAT1a  AANAT2  Sheep AANAT 
β5  M154I  I157M  M159 
α2  -  L69R + N70H + G73T + Q74L  Q71 + H72 + T75 + L76 
β4  -  S123A  A125 
αa  -  M107L  L109 
a Region definition is after Hickman et al. [15] and Dyda et al. [2]. 
b AANAT1a- α2, β4 and αa mutants were inactive and therefore were not analyzed.  
Analysis of the acetylation activity of wild type and mutant proteins was done with serotonin and 
tryptamine  (indolethylamines)  and  dopamine  and  phenylethylamine  (phenylethylamines).  Figure  2 
represents acetylation activity with serotonin and phenylethylamine, which are generally similar to the 
kinetics found with tryptamine and dopamine, respectively. Table 2 represents the catalytic efficiency 
in terms of Kcat/Km values. Acetylation of phenylethylamine and dopamine by AANAT2 mutants did 
not obey the Michaelis-Menten equation (Figure 2), and their activities are therefore expressed relative 
to wild type AANAT2 activity in the presence of 10 mM substrate (shaded values, Table 2); these Mar. Drugs 2011, 9                      
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values cannot be compared to other enzyme-substrate Kcat/Km values. The specific effect of each 
mutation is detailed below.  
Figure 2. Acetylation of arylalkylamines by wild type and mutant AANATs. Activities 
were  measured  in  the  presence  of  near  saturating  levels  of  AcCoA  and  increasing 
concentration of amine substrates. The graphs represent acetylation activities (mean ±  SE) 
with  serotonin  and  phenylethylamine.  A  generally  similar  kinetics  was  found  with 
tryptamine and dopamine. The AANAT1a- α2, β4 and αa mutants did not express well and 
were  inactive,  consistent  with  misfolding,  and  therefore  were  not  analyzed  (see 
‗Experimental  Section‘  for  details).  (A)  AANAT1a  and  mutants  with  serotonin;  
(B)  AANAT1a  and  mutants  with  phenylethylamine;  (C)  AANAT2  and  mutants  with 
serotonin; (D) AANAT2 and mutants with phenylethylamine; PEA =  phenylethylamine. 
 
Table  2.  Apparent Kcat/Km values (mean ±  SE) of wild type and mutant proteins for 
serotonin, tryptamine, dopamine and phenylethylamine. 
  AANAT1a  AANAT2 
  Wild type  β5  Wild type  β5  α2  β4  αa 
Serotonin  61.36 ±  4.39  64.15 ±  3.49  6.60 ±  0.54  11.34 ±  0.93  17.65 ±  1.06  18.58 ±  1.41  7.29 ±  0.54 
Tryptamine  23.37 ±  1.59  14.84 ±  0.60  3.19 ±  0.25  8.50 ±  0.69  6.62 ±  0.33  9.06 ±  0.78  1.46 ±  0.003 
Dopamine  7.30 ±  0.54  1.86 ±  0.49  1  2.40 ±  0.10  3.80 ±  0.07  2.48 ±  0.18  0.65 ±  0.03 
Phenylethylamine  32.86 ±  2.74  5.05 ±  0.61  1  2.52 ±  0.26  4.33 ±  0.56  3.03 ±  0.09  0.61 ±  0.03 
Note: Acetylation of phenylethylamine and dopamine by AANAT2 mutants are expressed relative to wild 
type and are indicated as shaded values. Mar. Drugs 2011, 9                      
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2.1.1. β5 Mutations 
Met
159 is one of six residues that form the amine substrate binding pocket in sheep AANAT [15]. It 
forms  a  hydrogen  bond  with  the  nitrogen  of  the  amine  substrate  and  is  therefore  crucial  for  
its stabilization.  
The results showed that substitution of Ile to Met in AANAT2 (mutation β5 of AANAT2) increased 
the ability of AANAT2 to acetylate phenylethylamines by ~2.5-fold (p < 0.05) as compared to wild 
type, and also increased its affinity to indolethylamines (Km = 0.90 mM vs. 2.0 mM of wild type for 
tryptamine and Km = 0.94 mM vs. 2.2 mM of wild type for serotonin), resulting in a 2- to 3-fold 
increase  (p  <  0.05)  in  the  Kcat/Km  values  (Table  2,  Figure  2).  The  reciprocal  β5  mutation  of 
AANAT1a  (M154I)  reduced  AANAT1a  capacity  to  acetylate  dopamine  and  phenylethylamine  by  
3.9-  and  6.5-fold  (p  <  0.01),  respectively,  but  reduced  tryptamine  acetylation  by  only  1.6-fold  
(p < 0.05), while having almost no effect on its capacity to acetylate serotonin (Table 2, Figure 2), 
indicating that the decrease in phenylethylamines acetylation is specifically related to the mutation. 
These results suggest that the Met/Ile difference in this position contributes to the different kinetic 
characteristics and the low ability of AANAT2 to acetylate phenylethylamines. 
The  importance  of  the  hydrogen  bond  formed  at  this  site  (Met
159  in  sheep  AANAT)  to  the 
stabilization of the amine substrate was previously emphasized [2,15]. The contribution of this site to 
the  catalytic  mechanism  of  AANATs  is  now  expanded  to  include  determination  of  substrate 
selectivity. It is notable that an evolutionary substitution of two neutral residues, Met
154 in AANAT1a 
by Ile
157 in AANAT2, has a profound effect on substrate preference. 
2.1.2. α2 Mutation 
The α2 region is a component of loop 1 which was recognized as the most floppy part of the 
enzyme [14,15,35]. The binding of AcCoA displaces loop 1 and leads to reorganization of helices α1 
and  α2  at  both  ends  of  the  loop.  This  conformational  change  contributes  to  the  formation  of  the 
arylalkylamine  binding  pocket  [14,15].  Interestingly,  this  small  region  contains  changes  in  five 
adjacent amino acids that characterize fish AANAT2. The mutations of α2 region changed two pairs of 
adjacent amino acids. 
This mutation increased AANAT2 ability to acetylate dopamine and phenylethylamine by 3.80- and 
4.33-  fold,  (p  <  0.05)  respectively  as  compared  to  wild  type;  and  increased  its  affinity  to 
indolethylamines (1.2 mM for tryptamine and 0.88mM for serotonin), as reflected in a 2- to 2.5- fold 
increase  (p  <  0.05)  in  the  Kcat/Km  values  (Table  2,  Figure  2).  The  α2  mutation  conferred  upon 
AANAT2 the highest increase of phenylethylamines acetylation among the four AANAT2 mutants. 
The results  strengthen previous studies showing the importance of this  region  for the catalytic 
action of the AANAT  enzymes.  Furthermore, it  suggests that evolutionary changes  within the α2 
region  of  AANAT2  underlie  the  structural  changes  that  may  contribute  to  its  low  capacity  to  
acetylate phenylethylamines.  Mar. Drugs 2011, 9                      
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2.1.3. β4 Mutation 
The β4 region is located within the most conserved motif of the GNAT superfamily which is the 
site of AcCoA binding and contains residues that participate in the catalytic reaction [2]. 
The results show that substitution of Ser to Ala in AANAT2 (Mutation β4 of AANAT2) increased 
the ability of AANAT2 to acetylate dopamine and phenylethylamine by 2.48- (p < 0.05) and 3.03- 
fold,  (p  =  0.079),  respectively.  This  mutation  also  increased  the  affinity  of  AANAT2  for 
indolethylamines (0.65 mM for tryptamine and 0.65mM for serotonin), as reflected in the ~3-fold  
(p < 0.05) increase in the Kcat/Km values (Table 2, Figure 2).  
These results support previous studies showing that the β4 region is important for the catalytic 
reaction of the AANAT enzymes, and specifically suggest that Ala
120 (in AANAT1a) and Ser
123 (in 
AANAT2) are involved in determining the kinetics and substrate preference of these enzymes.  
2.1.4. αa Mutation 
αa is a subdomain of the two-turn helix that is located between the β3 and β4 sheets [14]. This helix 
defines a ―third wall‖ in the amine binding site that almost entirely encloses the catalytic funnel, and 
exists  only  in  the  AANAT  family  and  not  in  other  members  of  the  GNAT  superfamily  [2]. 
Specifically, residue Leu-109 of the Sheep AANAT was reported to be part of the serotonin binding 
site [15]. The corresponding substitution of Met to Leu in AANAT2 (mutation αa of AANAT2) did 
not effect phenylethylamines or indolethylamines acetylation activities in comparison to wild type 
(Table 2, Figure 2). These results suggest that Leu
104 (AANAT1a) and Met
107 (AANAT2), which 
participate in the serotonin binding site, do not contribute to the differences in the substrate preference 
of these enzymes. 
2.2. Inhibition Experiments 
Two  reasons  may  account  for  the  low  ability  of  AANAT2  to  acetylate  phenylethylamines:  
(1) phenylethylamines do not bind to the catalytic pocket of AANAT2; or, (2) phenylethylamines do 
bind to the catalytic pocket of AANAT2 but are not acetylated by the enzyme. In the latter case, an 
inhibition of indolethylamines acetylation would be expected in the presence of phenylethylamines. To 
discriminate between the two options, acetylation of subsaturating tryptamine concentrations, at about 
the Km value of each enzyme (0.15 mM for AANAT1a and 1.5 mM for AANAT2) was measured in 
the absence or presence of increasing dopamine concentrations:  0.1 mM or 1mM for AANAT1a and 
AANAT2, respectively (~1× ); 1 mM or 10 mM for AANAT1a and AANAT2, respectively (~6× ); and 
5 mM or 50 mM for AANAT1a and AANAT2, respectively (~30× ) the tryptamine concentrations 
(Figure 3). Similar inhibition patterns (Pearson correlation, R = 0.87, p = 0.024) were found for both 
enzymes, with minimal inhibition at the 1:1 dopamine:tryptamine ratio, ~30% inhibition at the 6:1 
dopamine:tryptamine ratio, and ~ 60% inhibition at the 30:1 ratio (Figure 3). These results suggest that 
dopamine binds to the catalytic pockets of AANAT1a and AANAT2 at similar affinities, which are 
lower than those of tryptamine. Mar. Drugs 2011, 9                      
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Figure  3.  Dopamine  inhibits  tryptamine  acetylation  by  AANAT1a  and  AANAT2. 
Dopamine inhibition of tryptamine acetylation was analyzed using the radiochemical assay. 
The concentrations of tryptamine selected approximated the Km values of each enzyme 
(0.15  and  1.5  mM  for  AANAT1a  and  AANAT2,  respectively),  in  the  presence  of 
increasing concentrations of dopamine (0, 0.1, 1, 5 mM or 0, 1, 10, 50 mM for AANAT1a 
and AANAT2, respectively). Other conditions were as previously determined for wild type 
AANAT1a and AANAT2 [22]. Values are given as mean ±  SE. 
 
The amine binding pocket  of AANATs  constitutes  a small edge of the catalytic funnel  that  is 
surrounded by hydrophobic residues. The dominant factor that determines which molecules will enter 
the  funnel  is  size;  and the  main  forces  that  hold  the  amines  are  van  der  Waals‘  interactions  and 
hydrophobic packing [14,15]. 
The catalytic mechanism of AANAT, like other members of the GNAT superfamily, involves an 
acetyl transfer from AcCoA to the acceptor through a direct nucleophilic attack. Although members of 
the GNAT superfamily acetylate a wide variety of substrates and exhibit low amino acids sequence 
identity, the structural conservation of the AcCoA binding site is remarkably high [2,36]. The catalytic 
mechanism of AANATs depends on proper orientation of the amine and thioacetyl groups, which are 
stabilized by three hydrogen bonds [2,15]. 
These  inhibition  experiments  suggested  that  phenylethylamines  bind  to  the  AANAT2  catalytic 
pocket although they are poorly acetylated by the enzyme. This may happen if their spatial and/or 
electrostatic binding within the catalytic pocket does not allow efficient catalysis. 
2.3. AANAT1a and AANAT2 Have Similar Predicted Binding Capacities 
Structural analysis. Since phenylethylamines appear to bind to the catalytic pocket of AANAT2, it 
may be hypothesized that the kinetic differences and substrate preferences between the two enzymes 
stem from differences in the spatial relationships between the bound substrate and catalytic residues. 
This hypothesis was further explored by investigating the predicted 3-D structures of the seabream 
AANAT1a and AANAT2, using the structure of the sheep AANAT-bisubstrate analog complex PDB 
accession  number:  1CJW  [15]  as  a  template.  General  surface  and  electrostatic  properties  were 
evaluated to assess the similarities and differences between the catalytic funnels of the two enzymes. Mar. Drugs 2011, 9                      
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Figure 4 depicts the curvature analysis of the surface (upper panels), and the electrostatic properties 
analysis (lower panels) of the catalytic funnel of AANAT1a and AANAT2. The overall topology of 
the funnel in the AANAT1a and AANAT2 models is fairly similar, with some minor differences. One 
stems from the presence of Leu
181 vs. Met
184 in AANAT1a and AANAT2, respectively. The longer 
side chain of the Met
184 (colored blue) projects to the cavity (lower part of the pocket), and covers part 
of Ile
181 of AANAT2 (colored green). It should be noted however that the Leu
181 to Met
184 and the 
Val
178 to Ile
181 changes have been found only in seabream AANATs, not in other known AANATs. 
Another topological difference, in the vicinity of the catalytic histidine residues (His
115 and His
117 in 
AANAT1a, His
118 and His
120 in AANAT2), is an enlargement of the cavity in AANAT2 as compared 
to that of AANAT1a (upper part of the cavity, Figure 4). In addition, the charge distribution between 
the two histidines and in the vicinity of Met
154 (AANAT1a) and Ile
157 (AANAT2) is different. 
As  suggested  by  the  inhibition  experiments,  the  relatively  minor  chemophysical  differences 
between  the  two  enzymes  do  not  suggest  limitations  on  the  binding  of  phenylethylamines  to  the 
AANAT2 pocket. However, since the catalytic event is based on proper orientation of the ternary 
intermediate complex [2], these minor differences in topology and electrostatic fields may affect the 
efficiency of the catalysis.  
2.4. In Silico Assessment of Binding Stability 
Docking experiments are another bioinformatics tool that can be used to explore enzyme-substrate 
relationships,  by  predicting  the  probability  of  enzyme-substrate  binding.  Therefore,  rigid  docking 
experiments  were  performed  in  order  to  assess  the  binding  stability  of  AANAT1a,  AANAT2  or  
β5-AANAT2, and indolethylamines (serotonin and tryptamine) or phenylethylamines (dopamine and 
phenylethylamine), based on their geometric complementarity. Analysis of the spatial binding showed 
that phenylethylamines bind to the same region of AANAT2 as indolethylamines. This strengthens the 
hypothesis that the inhibition of tryptamine acetylation by dopamine (Figure 3) is due to competitive 
binding of tryptamine and dopamine within the catalytic pocket of AANAT2. Analyses of the binding 
stability values (supplementary data, Table S1) indicate that both AANAT1 and ANNAT2 have better 
geometric complementarity with indolethylamines than with phenylethylamines, as reflected in the 
~13% decrease in the binding stability values for each enzyme. This is in agreement with the measured 
activities of AANATs, which indicate that indolethylamines are the better substrates for both enzymes 
(Figure 2; [22]). Moreover, in agreement with the results of the inhibition experiments (Figure 3), 
stable AANAT2-phenylethylamines complexes were predicted with values that were similar (>99%) to 
those of AANAT1a-phenylethylamines complexes, suggesting that phenylethylamines bind AANAT1a 
and AANAT2 pockets with similar efficiencies. This result supports the outcome of the inhibition 
experiments and the predicted 3-D structures analyses, suggesting that the kinetic differences between 
the two enzymes stem from differences in the spatial relationships between the bound substrate and 
catalytic  residues,  which  determine  the  proximity  of  the  amine  to  the  thioacetyl  group  and  
neighboring residues. 
 Mar. Drugs 2011, 9                      
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Figure  4.  3-D  surface  properties  of  the  catalytic  funnel  of  seabream  AANAT1a  and 
AANAT2. The 3-D models of AANAT1a (left panels) and AANAT2 (right panels) were 
reconstructed based on the 3-D structure of the sheep AANAT complex with a bisubstrate 
analog [15]. The curvature analysis of the surface is shown on the upper part of the picture, 
with the innermost regions colored in grey and the outermost in green (see scale bar). The 
lower part of the picture depicts the electrostatic properties analysis of the funnel, with the 
positive parts colored in blue and the negative parts in red (see scale bar). Residues that 
form  the  amine  binding  site  and  catalytic  residues  are  colored  as  follows: 
Phe
51(AANAT1a) and Phe
54 (AANAT2), red; Pro
59 (AANAT1a) and Pro
62 (AANAT2), 
yellow; Met
154 (AANAT1a) and Ile
157 (AANAT2), magenta; Val
178 (AANAT1a) and Ile
181 
(AANAT2), green; Leu
181 (AANAT1a) and Met
184 (AANAT2), blue; His
115 (AANAT1a) 
and  His
118  (AANAT2),  cyan;  His
117  (AANAT1a)  and  His
120  (AANAT2),  grey.  Grasp 
software package was used for the surface property analysis. 
Pro62 Pro59
His117 His120
His115 His118 Phe51 Phe54
Met154
Ile157
Ile181 Val178
Leu181 Met184
AANAT1a
AANAT2
AANAT2
AANAT1a
 
A possible extension of this hypothesis stems from the increased affinity of the AANAT2 mutants, 
not only to the phenylethylamines but also to the indolethylamine substrates (Table 2, Figure 2). This 
finding suggests that the substrate selectivity of AANAT2 is an outcome of its general low affinity, 
even  for  its  preferred  substrates,  which  results  in  an  almost  total  reduction  of  activity  with 
phenylethylamines. However, it should be noted that the reciprocal effect was not observed, i.e., the 
reaction rate of β5-AANAT1a with indolethylamines was only slightly decreased as compared to the Mar. Drugs 2011, 9                      
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wild type AANAT1a. Nevertheless, it is likely that this phenomenon at least partially contributes to the 
different substrate preferences of the two enzymes.  
Multiple functions of fish AANATs are consistent with the hypothesis that the ancestral AANAT 
evolved as a detoxification enzyme in the primitive photoreceptor [30,31]. Later in evolution, when 
melatonin became an important signal, its increased production became a pineal gland-specific feature 
in order to avoid toxic processes within the visual phothoreceptor cell. Consequently, current AANAT 
expression  in  the  vertebrate  retina  may  reflect  its  ancestral-conserved  function  as  a  detoxification 
enzyme. The expression of AANAT in extra-pineal and extra-retinal sites including the brain [37–40], 
raises  the  hypothesis  that  this  enzyme  is  involved  in  detoxification  functions  in  these  tissues.  Of 
special interest is the idea that AANAT acetylates dopamine in the brain.  
The results of the current study provide a possible molecular-structural mechanism for the substrate 
specificity of the two paralog AANATs, and demonstrate how changes in the coding sequence may 
have  led  to  the  formation  of  two  enzymes  with  different  biochemical  properties  and  possibly  
different functions. 
3. Experimental Section 
3.1. Mutant Design  
Candidate residues that control substrate preference of AANAT1a and AANAT2 were identified 
using site-directed mutagenesis. Mutations were selected based on: (1) the uniqueness of residues that 
characterize fish AANTA2 vs. fish AANAT1s and AANATs of other vertebrates (multiple sequence 
alignment, ClustalW 1.82); and  (2) the deduced or demonstrated importance of the region for the 
catalytic activity or substrate binding [13,15,17]. AANTA1a and AANAT2 were mutated by reciprocal 
substitutions. For example, in mutation β5 (Table 1), Met
154 in AANAT1a was changed to Ile which 
occupies the corresponding position in AANAT2 and vice versa. A description of each mutant enzyme 
is presented in Table 1. 
3.2. Preparation of Wild Type and Mutant Proteins 
Wild type and mutant proteins were expressed as GST fusion proteins. Seabream AANAT1a and 
AANAT2 expression vectors, psb1ex and psb2ex, respectively [22], were used as templates to prepare 
mutant  protein expression vectors using the  Quickchange PCR-based  site-directed mutagenesis  kit 
(Stratagene, La Jolla, CA, USA). Mutations were performed according to manufacturer‘s instructions, 
and were verified by DNA sequencing. Plasmid vectors (pGEX-4T-1, Amersham) containing the wild 
type or mutant coding region were transformed into BL21 E. coli. Proteins were produced and purified 
as described [22]. Purity and concentration of the purified recombinant proteins were determined by 
10%  SDS-polyacrylamide  gel  electrophoresis  and  Bradford  assay,  respectively.  Protein  aliquots  
(10 µL) were stored at −80 C. The preparations of the wild type and mutant AANAT2s yielded high 
expression and purity (~80%) and the proteins exhibited acetylation activities (see results). Wild type 
AANAT1a  and  mutant  β5-AANAT1a  had  lower  expression,  were  isolated  at  ~70%  purity  and 
exhibited acetylation activities. Mutant proteins α2-, β4- and αa-AANAT1a did not express well and 
were inactive, consistent with misfolding, and therefore were not analyzed.  Mar. Drugs 2011, 9                      
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3.3. Assay of AANAT Activity 
A colorimetric assay was used to measure the activity of wild type and mutant proteins. This assay 
is based on the quantification of CoASH generated during acetyl transfer [12,41]. Standard reactions 
for wild type and mutated proteins were as previously described for AANAT1a and AANAT2 [22] in 
the  presence  of  the  indicated  concentrations  of  amine  substrates.  Assays  were  done  2–3  times  in 
duplicate. Apparent Km and Kcat values were calculated by multiple non-linear regressions, using the 
program GOSA [42], and are presented as mean ±  SE. 
A radiochemical assay [43] was used to determine the activity of wild type proteins in ‗inhibition 
experiments‘  which  were  designed  to  determine  the  effect  of  dopamine  on  the  acetylation  of 
tryptamine. Wild type proteins (25 nM) were incubated with the indicated concentration of tryptamine 
and dopamine and 0.5 mM 
3H-acetyl-coenzyme A (4.1 Ci/mmol, Amersham, Buckinghamshire, UK), 
in  a  final  volume  of  100  µL  for  40  min,  at  optimal  conditions  of  each  enzyme.  The  product  
N-[
3H]-acetyltryptamine  was  extracted  into  chloroform;  this  procedure  does  not  extract 
acetyldopamine. The chloroform was evaporated and the residue was redissolved in scintillation fluid 
for counting. Assays were done twice in duplicate and are presented as mean ±  SE. 
3.4. Structural Analysis 
Pairwise alignment of seabream AANAT1a (GenBank accession number: AY533402), AANAT2 
(GenBank accession number: AY533403), and sheep AANAT (Uniprot accession number: 002785) 
(Figure 1) was done using the Needle alignment tool [44,45], and was used as a basis for the homology 
modeling of the 3-D models of the seabream AANAT1a and AANAT2. 
The structure-modeling package JACKAL (Nest module, [46]) was used to calculate the AANAT1a 
and  AANAT2  structures,  based  on  the  template  structure  of  sheep  AANAT  in  complex  with  a 
bisubstrate analog (PDB entry: 1CJW). The stereochemical quality of the models was checked using 
the PROCHECK suite [47]. The PROC-AVA values were 0.35 and 0.3 for AANAT1a and AANAT2, 
respectively, indicating high structural reliability. In addition, the resulting models were compared to 
models calculated using the ModBase modeling server [48]. The structure models were found to be 
similar in  both  modeling methods.  Hydrogen atoms  were added using  H++ server  [49] under the 
following conditions: pH = 6.5, I = 0.15 M, ε_in = 6, ε_out = 80. The 3-D calculated models of 
AANAT1a  and  AANTA2  are  provided  upon  request.  Grasp  software  package  [50]  was  used  for 
surface property analysis (same conditions as above). Assessments of the binding stability between 
AANAT1a,  AANAT2,  or  β5-AANAT2  and  indolethylamines  (serotonin  and  tryptamine)  or 
phenylethylamines  (dopamine  and  phenylethylamine),  were  obtained  by  rigid  docking  based  on 
geometric complementarity of the protein and substrate (PatchDock server, [51,52]. 
3.5. Statistical Analysis 
Differences in acetylation activity between wild type AANAT1a and its mutant were evaluated 
using t-test. Differences between wild type AANAT2 and its mutants were evaluated using one sample 
t-test  for  phenylethylamine  substrates  or  by  analysis  of  variance  (ANOVA)  followed  by  Tukey‘s  Mar. Drugs 2011, 9                      
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post-hoc  test  for  the  indolethylamine  substrates.  To  test  similarity  of  dopamine  inhibition  effect 
between AANAT1a and AANAT2, Pearson‘s correlation was carried out. 
4. Conclusions 
In the current study, the bases for the biochemical properties and substrate specificity differences 
between AANAT1a and AANAT2 paralogs were biochemically investigated, followed by supporting 
in silico experiments. The results suggest that the kinetics of these enzymes is determined by the 
accessibility of the bound substrate to catalytic residues within the catalytic pocket. This expands the 
understanding of substrate selectivity and mechanism of action of the AANAT enzyme family, and 
may be useful for the development of specific inhibitors of AANAT, which are of special interest for 
melatonin-related clinical applications such as sleep disorders, and jet lag or mood disorders, in which 
serotonin and dopamine are involved. 
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